Please assess the completion status of the following clinical trial:

Trial Title: A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated Malaria

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male or female, older than 12 months.~* Weight \> 10 kg.~* Diagnoses of uncomplicated acute P. falciparum malaria parasitaemia of up to 500 000 asexual parasite/mcl blood with axillary temperature of greater than and equal to 37.50C or history of fever.~* Documented informed consent.~* Lives close enough to the health centre for reliable follow up.~Exclusion Criteria:~* Has received anti-malarial treatment in the past 7 days.~* Is infected with other malarial species (such subjects will be excluded retrospectively).~* Severely ill (based on WHO Criteria for severe malaria ) or if patient is considered, in the opinion of the investigator or designee, to have moderately severe malaria (e.g. prostrate, repeated vomiting, dehydrated).~* Has received cotrimoxazole or chloramphenicol in the past 7 days.~* History of G6PD deficiency.~* Is pregnant.~* Has a history of allergy to any sulphonamide (for SP) or artemisinin derivative (for artesunate and co-artemether).

- Gender: ALL
- Minimum Age: 12 Months
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).